Total Equity - Cytosorbents Corp (NASDAQ:CTSO) - Alpha Spread

Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager
Cytosorbents Corp Logo
Cytosorbents Corp
NASDAQ:CTSO
Watchlist
Price: 1.42 USD Market Closed
Market Cap: 77.1m USD
Have any thoughts about
Cytosorbents Corp?
Write Note

Cytosorbents Corp
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cytosorbents Corp
Total Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Cytosorbents Corp
NASDAQ:CTSO
Total Equity
$16.7m
CAGR 3-Years
-39%
CAGR 5-Years
8%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Total Equity
$25.9B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Total Equity
$20.4B
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Total Equity
$19.8B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Total Equity
$39.3B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
5%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Equity
$14.7B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
18%

See Also

What is Cytosorbents Corp's Total Equity?
Total Equity
16.7m USD

Based on the financial report for Jun 30, 2024, Cytosorbents Corp's Total Equity amounts to 16.7m USD.

What is Cytosorbents Corp's Total Equity growth rate?
Total Equity CAGR 10Y
7%

Over the last year, the Total Equity growth was -31%. The average annual Total Equity growth rates for Cytosorbents Corp have been -39% over the past three years , 8% over the past five years , and 7% over the past ten years .

Back to Top